DEFERASIROX vs EXJADE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Attribute	DEFERASIROX	EXJADE
Rating	72/100	70/100
Pharmacy pays	~$38.05 /30	~$38.05 /30
Type	RX	RX
Active ingredient	DEFERASIROX	DEFERASIROX
Manufacturer	Actavis Elizabeth	Novartis
Dosage forms	Powder, Tablet	Tablet
Drug class	Iron Chelator	Iron Chelator
Boxed warning	None	Boxed warning
Half-life	about 8 to 16 hours (the label gives a mean elimination half-life range, not a single number)	about 8 to 16 hours (the label gives a mean elimination half-life range, not a single number)
Treats	Iron Overload	Iron Overload

deferasirox exjade

Rating

72/100

70/100

Pharmacy pays

~$38.05 /30

Type

Active ingredient

DEFERASIROX

Manufacturer

Actavis Elizabeth

Novartis

Dosage forms

Powder, Tablet

Tablet

Drug class

Iron Chelator

Boxed warning

None

Boxed warning

Half-life

about 8 to 16 hours (the label gives a mean elimination half-life range, not a single number)

Treats

Iron Overload

Frequently asked questions

Which is better-rated, Deferasirox or Exjade?

By our independent rating, Deferasirox scores higher — 3.6 vs 3.5 out of 5 for Exjade. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Deferasirox or Exjade?

Pharmacies pay about the same to acquire either one — roughly $38.05 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Deferasirox and Exjade?

Both Deferasirox and Exjade share the active ingredient Deferasirox.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.